Risk factors for serotype 19A carriage after introduction of 7-valent pneumococcal vaccination

被引:17
|
作者
Cohen, Robert [1 ,2 ]
Levy, Corinne [2 ]
Bonnet, Eric [3 ]
Thollot, Franck [4 ]
Boucherat, Michel [2 ]
Fritzell, Bernard [3 ]
Derkx, Veronique [2 ]
Bingen, Edouard [5 ]
Varon, Emmanuelle [6 ]
机构
[1] CHI Creteil, Dept Microbiol, Creteil, France
[2] Assoc Clin Therapeut Infantile Val de Marne, ACTIV, F-94100 St Maur Des Fosses, France
[3] Lab Pfizer, F-75014 Paris, France
[4] AFPA, F-54270 Esseys Les Nancy, France
[5] Univ Paris 07, Robert Debre Hosp, AP HP, Dept Microbiol, F-75019 Paris, France
[6] HEGP, AP HP, Natl Reference Ctr Pneumococci, F-75015 Paris, France
关键词
ACUTE OTITIS-MEDIA; STREPTOCOCCUS-PNEUMONIAE; NASOPHARYNGEAL CARRIAGE; POPULATION SNAPSHOT; CHILDREN; EMERGENCE;
D O I
10.1186/1471-2334-11-95
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Background: After the implementation of 7-valent pneumococcal conjugate vaccine (PCV7), in several countries, serotype 19A is now the serotype most frequently involved in pneumococcal diseases and carriage. To determine factors potentially related to 19A nasopharyngeal (NP) carriage we analyzed data from an ongoing prospective French national surveillance study of pneumococcal NP carriage in young children. Methods: NP swabs were obtained from children aged 6 to 24 months, either during routine check-ups with normal findings, or when they presented with acute otitis media (AOM). The swabs were sent for analysis to the French National Reference Centre for Pneumococci. Factors influencing pneumococcal carriage and carriage of penicillin non-susceptible (PNSP), 19A and PNS-19A were investigated by multivariate logistic regression. Results: From 2006 to 2009, 66 practitioners enrolled 3507 children (mean age 13.6 months), of whom, 98.3% of children had been vaccinated with PCV7 and 33.4% of children attended daycare centres (DCC). Serotype 19A was found in 10.4% of the overall population, 20.5% of S. pneumoniae carriers (n = 1780) and 40.8% of PNSP carriers (n = 799). Among 19A strains, 10.7% were penicillin-susceptible, 80% intermediate and 9.3% fully resistant. Logistic regression analysis showed that the main factors associated with PNSP carriage were AOM (OR = 3.09, 95% CI [2.39;3.98]), DCC (OR = 1.70, 95% CI [1.42;2.03]), and recent antibiotic use (OR = 1.24, 95% CI [1.05;1.47]. The main factors predictive of 19A carriage were recent antibiotic use (OR = 1.81, 95% CI [1.42;2.30]), AOM (OR = 1.67, 95% CI [1.11;2.49]), DCC (OR = 1.56, 95% CI [1.21;2.2] and young age, < 12 months (OR = 1.51, 95% CI [1.16;1.97]). Conclusion: In a population of children aged from 6 to 24 months with a high rate of PCV7 vaccination coverage, we found that antibiotic exposure, DCC attendance and AOM were linked to 19A carriage.
引用
收藏
页数:6
相关论文
共 50 条
  • [21] The impact of 10-valent and 13-valent pneumococcal conjugate vaccines on serotype 19A invasive pneumococcal disease
    Principi, Nicola
    Esposito, Susanna
    EXPERT REVIEW OF VACCINES, 2015, 14 (10) : 1359 - 1366
  • [22] Pneumococcal Meningitis Vaccine Breakthroughs and Failures After Routine 7-Valent and 13-Valent Pneumococcal Conjugate Vaccination in Children in France
    Godot, Cecile
    Levy, Corinne
    Varon, Emmanuelle
    Picard, Capucine
    Madhi, Fouad
    Cohen, Robert
    PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2015, 34 (10) : E260 - E263
  • [23] Impact of 7-valent pneumococcal conjugate vaccination in a population with low to intermediate vaccination levels
    Salleras, Lluis
    Dominguez, Angela
    Ciruela, Pilar
    Izquierdo, Conchita
    Borras, Eva
    ENFERMEDADES INFECCIOSAS Y MICROBIOLOGIA CLINICA, 2009, 27 (05): : 275 - 277
  • [24] Socioeconomic and Racial Disparities of Pediatric Invasive Pneumococcal Disease After the Introduction of the 7-valent Pneumococcal Conjugate Vaccine
    Spicer, Jennifer O.
    Thomas, Stephanie
    Holst, Amy
    Baughman, Wendy
    Farley, Monica M.
    PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2014, 33 (02) : 158 - 164
  • [25] Changing epidemiology of invasive pneumococcal disease in Australian children after introduction of a 7-valent pneumococcal conjugate vaccine
    Williams, Scott R.
    Mernagh, Paul J.
    Lee, Michael H. T.
    Tan, Jonathan T.
    MEDICAL JOURNAL OF AUSTRALIA, 2011, 194 (03) : 116 - 120
  • [26] Pneumococcal Carriage, Serotype Distribution, and Risk Factors in Children With Community-Acquired Pneumonia, 5 Years After Introduction of the 10-Valent Pneumococcal Conjugate Vaccine in Ethiopia
    Negash, Abel Abera
    Asrat, Daniel
    Abebe, Workeabeba
    Hailemariam, Tewodros
    Gebre, Meseret
    Verhaegen, Jan
    Aseffa, Abraham
    Vaneechoutte, Mario
    OPEN FORUM INFECTIOUS DISEASES, 2019, 6 (06):
  • [27] COST-EFFECTIVENESS OF 13-VALENT AND 10-VALENT PNEUMOCOCCAL CONJUGATE VACCINATION RELATIVE TO 7-VALENT PNEUMOCOCCAL CONJUGATE VACCINATION IN CANADA
    Whillans, F.
    Kwan, H.
    Strutton, D. R.
    Earnshaw, S. R.
    Farkouh, R.
    VALUE IN HEALTH, 2009, 12 (07) : A425 - A425
  • [28] Pneumococcal Nasopharyngeal Carriage following Reduced Doses of a 7-Valent Pneumococcal Conjugate Vaccine and a 23-Valent Pneumococcal Polysaccharide Vaccine Booster
    Russell, F. M.
    Carapetis, J. R.
    Satzke, C.
    Tikoduadua, L.
    Waqatakirewa, L.
    Chandra, R.
    Seduadua, A.
    Oftadeh, S.
    Cheung, Y. B.
    Gilbert, G. L.
    Mulholland, E. K.
    CLINICAL AND VACCINE IMMUNOLOGY, 2010, 17 (12) : 1970 - 1976
  • [29] Increased paediatric hospitalizations for empyema in Australia after introduction of the 7-valent pneumococcal conjugate vaccine
    Strachan, Roxanne E.
    Snelling, Thomas L.
    Jaffe, Adam
    BULLETIN OF THE WORLD HEALTH ORGANIZATION, 2013, 91 (03) : 167 - 173
  • [30] Decline in Child Hospitalization and Mortality after the Introduction of the 7-Valent Pneumococcal Conjugative Vaccine in Rwanda
    Rurangwa, Janvier
    Rujeni, Nadine
    AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, 2016, 95 (03): : 680 - 682